New York State Common Retirement Fund Atossa Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.85 - $1.28 $45,985 - $69,248	-54,100 Reduced 98.31%	928 $1,000
Q4 2021 Feb 02, 2022	SELL	$1.6 - $3.27 $468 - $958	-293 Reduced 0.53%	55,028 $88,000
Q3 2021 Nov 02, 2021	SELL	$2.89 - $6.4 $129,700 - $287,225	-44,879 Reduced 44.79%	55,321 $180,000
Q2 2021 Aug 02, 2021	BUY	$1.52 - $8.62 $152,304 - $863,723	100,200 New	100,200 $633,000

19.3M

95K

82.4K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $147M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.